Embed
Email

Immunization

Document Sample

Shared by: gegeshandong
Categories
Tags
Stats
views:
1
posted:
11/6/2011
language:
English
pages:
41
Immunization

Dr. Mohammed Farouq

Objectives

 Types of vaccination

 Contraindications

 Discussion of individual vaccines

 Preparations

 Administration

 Precautions and contraindications

 Side effects

Active Immunization

Types

 Live attenuated

 Virus Measles, mumps, rubella

 Bacteria BCG

 Killed

 Virus Hepatitis B

 Bacteria

 Whole Pertussis

 Toxoid Tetanus

 Polysaccharide Meningoccocal

Human Immune Serum Globulin



 Specific

 IM Hepatitis B (HBIG)

Rabies (RIG)

Tetanus (TIG)

Varicella (VZIG)



 IV CMV (CMV-IG)

RSV (RSV-IG)

Human Immune Serum Globulin



 Non-specific

 IM Immune serum globulin(ISG)

 Hepatitis A

 Measles



 IV Intravenous immune globulin(IGIV)

 Antibody deficiency disorders

 ITP



 Kawasaki syndrome

Passive Immunization (Cont)



 SPECIFIC EQUINE ANTIBODIES (IM)

 BOTULISM ANTITOXIN

 DIPHTERIA ANTITOXIN

 TETANUS ANTITOXIN

 SNAKE & SPIDER ANTI-VENOM

 MONOCLONAL ANTIBODIES (IV)

 ANTI-ENDOTOXIN ANTIBODIES

Recommended Immunization

Schedule

for KSA 2010

RECOMMENDED AGE VACCINE(S)



BIRTH BCG, Hepatitis B (HBV)

2 MONTHS [DTP, HIB, HBV] [PCV]

Injectable Polio Vaccine (IPV)

4 MONTHS [DTP, HIB ] [PCV]

Oral Polio Vaccine (OPV)

6 MONTHS [DTP, HIB, HBV] ] [PCV]

Oral Polio Vaccine (OPV)

9 MONTHS Measles vaccine (mono)

12 MONTHS Oral Polio Vaccine (OPV)

MMR

Varicella

1 8 MONTHS Oral Polio Vaccine (OPV)

DTP, HIB, PCV

Hepatitis A

24 MONTHS Hepatitis A

4 – 6 YEARS Oral Polio Vaccine (OPV)

DTP

MMR

Varicella

General Contraindications



 Moderate or severe illness with or without fever

 Anaphylactic reaction to vaccine or vaccine

constituent

 Live attenuated vaccines

 Pregnant women



 Immunocompromised / Immunosuppressed

children

 within 3-11 months of immunoglobulin

administration

Invalid Contraindications

 Mild to moderate local reaction

 Mild acute illness with or without low grade fever

 Current antimicrobial therapy

 Convalescent phase of illnesses

 Prematurity and low birth weight

 History of penicillin or other nonspecific allergies

 Malnutrition

Immunization Of Special Groups



IMMUNOCOMPROMISED HOSTS

 Avoid MMR, measles (may be used in HIV)

 Avoid OPV; use IPV for these children and their

household contacts



PRETERM INFANTS

 Treat as term babies

 Avoid OPV in hospital

 Influenza vaccine in BPD

 may delay HBV if 7 years : Td, TdaP

 ADMINISTRATION

 IM

Diphtheria, Tetanus & Pertussis (DTP)



 CONTRAINDICATIONS (CI)

 Encephalopathy within 7 days

 Progressive or unstable neurological disorders

 Anaphylactic reaction to a previous dose

 PRECAUTIONS

 severe systemic reactions such as

 Temp > 40.50C



 persistent inconsolable crying > 3 hours



 Collapse episodes



 Convulsions

Measles, Mumps & Rubella (MMR)



 PREPARATIONS:

 MEASLES.

 MMR.

 ADMINISTRATION:

 SC.

 INDICATIONS:

 Primary immunization at 1 & 6 years.

Measles, Mumps & Rubella (MMR)



PRECAUTIONS & CONTRAINDICATIONS

 Pregnancy



 Anaphylaxis to eggs



 Immunodeficiency and

immunosuppression

 Immunoglobulins within 3-11 months

Measles, Mumps & Rubella (MMR)



 ADVERSE REACTIONS

 Fever ,rash (7 days post vaccination)

 Arthralgia , arthritis (rubella)

 Encephalitis [rare] (measles, mumps)

 Suppression of PPD skin test (measles)

 Convulsions in prone children(measles)

 Thrombocytopenia

Haemophilus Influenzae Type B



 ADMINISTRATION

 IM

 2,4,6 months, booster at 15 months

 INDICATIONS

 Children under 5 years of age

 High risk children

 SIDE EFFECTS:

 Local pain and erythema

 Mild fever

Pneumococcal Prophylaxis



 PREPARATIONS:

 7 valent conjugated vaccine[PCV]

 Purified capsular polysaccharide of 23 serotypes

of Streptococcus pneumoniae [PPV]



 ADMINISTRATION:

 IM / SC

 PCV: 4 dose series to infants

 1 dose/booster 5 years

Pneumococcal Prophylaxis



 INDICATIONS:

 Primary vaccination (conjugate vaccine)



 children 2 yr. or older with



 Anatomical or functional asplenia



 Sickle cell disease



 Nephrotic syndrome



 Immunosuppression

Pneumococcal Prophylaxis



 SIDE EFFECTS:

 Soreness , erythema, fever, myalgia



 Anaphylactic reactions (rare)

Varicella Prophylaxis



 PREPARATIONS:

 Varivax vaccine (MSD)

 ADMINISTRATION:

 0.5 ml IM

 12 months and above……..2 doses

Varicella Prophylaxis



 INDICATIONS:

 All children 12 months-18 years: (if no

history of varicella)

 EFFICACY:

 70-90%

Varicella Prophylaxis



 PRECAUTIONS & CONTRAITNDICATIONS:

 Immunocompromised patients

 Within 5 months of IG

 Children on long term salicylates

 SIDE EFFECTS:

 Fever , rash

 Zoster

Hepatitis A



 NATURE OF VACCINE:

 Killed formalin inactivated vaccine.



 PREPARATIONS:

 Various preparations available



e.g. Havrix 720 Junior, Havrix 1440 etc.

Hepatitis A



 INDICATIONS:

 children 1 year and above



 Susceptible children in endemic areas



 Chronic liver disease



 Hemophilia

Hepatitis A



 ADMINISTRATION:

 IM injection



 2 doses, at least 6 months apart



 ADVERSE REACTIONS:

 Local reactions, fever



 Rare: anaphylaxis

Additional Vaccines

Meningococcal Prophylaxis



 PREPARATIONS:

 monovalent (A or C)



 bivalent (A & C)



 quadrivalent (A,C,Y & W-135)



 quadrivalent conjugate quadrivalent



 ADMINISTRATION:

 SC

Meningococcal Prophylaxis



 INDICATIONS:

 Control of outbreaks



 Children with complement deficiencies

or asplenia

 SIDE EFFECTS:

 local erythema and discomfort



 transient fever

Influenza Virus

 Nature of vaccine:

 Killed vaccine.

 Live attenuated

 Preparations:

 whole and “split virus” vaccines.

 “split virus” vaccines are recommended for

children 6 months and older.

 composition of the vaccine is changed

annually.

Influenza Virus



 ADMINISTRATION:

 IM (killed).

 Live attenuated (intranasal).

 1 dose during influenzae season.

 Children 6months-9 years should receive an

additional dose, 4 weeks after the 1st dose, if

not previously immunized.

Influenza Virus

 Indications:

 chronic cardio-respiratory disease

 asthma



 cystic fibrosis



 bronchopulmonary dysplasia

Influenza Virus

 Indications:

 Sickle cell anemia.

 Chronic salicylate therapy.

 Diabetes mellitus.

 Chronic renal disease.

 Chronic metabolic disease.

 immunosuppressive conditions: cancer, HIV etc.

 Hospital personnel with significant patient

contact.

Influenza Virus

 Contraindication:

 Anaphylaxis to previous dose.

 Hypersensitivity to eggs.



 Adverse Reaction:

 Soreness at injection site.

 Allergic response.



 Guillain-Barré Syndrome.

New Vaccines

 Rota virus vaccines

 Human papilloma virus vaccine



Related docs
Other docs by gegeshandong
Centre of mass - Maths - it_
Views: 0  |  Downloads: 0
Chapters 11 12
Views: 5  |  Downloads: 0
TFC-MS100 - Hespro
Views: 0  |  Downloads: 0
836329-9.4 Pneumonia Consent Form
Views: 0  |  Downloads: 0
19089
Views: 0  |  Downloads: 0
By registering with docstoc.com you agree to our
privacy policy

You are almost ready to download!

You are almost ready to download!